GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shengda Bio-Pharm Co Ltd (SHSE:603079) » Definitions » EBITDA Margin %

Zhejiang Shengda Bio-Pharm Co (SHSE:603079) EBITDA Margin % : 13.77% (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Shengda Bio-Pharm Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Zhejiang Shengda Bio-Pharm Co's EBITDA for the three months ended in Mar. 2025 was ¥28.0 Mil. Zhejiang Shengda Bio-Pharm Co's Revenue for the three months ended in Mar. 2025 was ¥203.2 Mil. Therefore, Zhejiang Shengda Bio-Pharm Co's EBITDA margin for the quarter that ended in Mar. 2025 was 13.77%.


Zhejiang Shengda Bio-Pharm Co EBITDA Margin % Historical Data

The historical data trend for Zhejiang Shengda Bio-Pharm Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Shengda Bio-Pharm Co EBITDA Margin % Chart

Zhejiang Shengda Bio-Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.28 19.19 14.71 3.97 15.24

Zhejiang Shengda Bio-Pharm Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.41 8.46 5.02 6.80 13.77

Competitive Comparison of Zhejiang Shengda Bio-Pharm Co's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Shengda Bio-Pharm Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Shengda Bio-Pharm Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Shengda Bio-Pharm Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Zhejiang Shengda Bio-Pharm Co's EBITDA Margin % falls into.


;
;

Zhejiang Shengda Bio-Pharm Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Zhejiang Shengda Bio-Pharm Co's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=126.084/827.402
=15.24 %

Zhejiang Shengda Bio-Pharm Co's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=27.987/203.226
=13.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Shengda Bio-Pharm Co  (SHSE:603079) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Zhejiang Shengda Bio-Pharm Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Zhejiang Shengda Bio-Pharm Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Shengda Bio-Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
No.789, Renmin East Road, Chicheng Street, Tiantai County, Zhejiang Province, Hangzhou, CHN, 317200
Zhejiang Shengda Bio-Pharm Co Ltd is a pharmaceutical company. It is mainly engaged in the research and development, and production of biotin and biological preservatives. Its product portfolio includes biotin, folic acid and other vitamin products, as well as nisin and natamycin.
Executives
Pang Ai Ming Director
Zhu Yong Gang Director

Zhejiang Shengda Bio-Pharm Co Headlines

No Headlines